Arden responds to suit
This article was originally published in The Rose Sheet
Executive Summary
Lawsuit filed by The Stephan Company against Elizabeth Arden for infringing its federally registered Interlude trademark is "entirely without merit," Elizabeth Arden states in June 22 press release responding to allegations. "In fact, the U.S. Trademark Office granted Elizabeth Arden a registration for the Provocative Interlude name and will fully assert its legal rights in this matter," Arden adds. Filed in the U.S. District Court for the Southern District of New York, Stephan's suit seeks an injunction barring Elizabeth Arden from selling Provocative Interlude fragrance and products (1"The Rose Sheet" June 26, 2006, In Brief)...
You may also be interested in...
Suit against Arden
The Stephan Company has filed a lawsuit against Elizabeth Arden for infringing its federally registered Interlude trademark for personal care products and fragrances, company announces June 22. Filed in the U.S. District Court for the Southern District of New York, suit seeks an injunction barring Elizabeth Arden from selling Provocative Interlude fragrance and products, which are on sale in fine department stores. Arden launched Provocative Interlude in April (1"The Rose Sheet" April 3, 2006, Marketing In Brief). Stephan notes blocking further sales of the Provocative scent will prevent consumer confusion...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.